About Dr. Ramaswamy Valliappan
I am a board licensed physician seasoned as Pharmaceutical Physician (in Global Drug Development and Pharmacovigilance / Drug Safety) with over 23 plus years of experience as Co-Principal Investigator, Site Management, Clinical Development & Pharmacovigilance services across various transnational ITES, CROs and Pharmaceuticals to name a few like Accenture, Quintiles (IQVIA), Novartis Pharmaceuticals, Strides Arcolab, Stelis Biopharma, Bioclinica (Qinecsa), and more. My expertise includes signal detection, Safety Risk Management Planning & Mitigation Strategies, Predictive Safety, Aggregate report writing, AI-PV strategy, Vaccines & Biologics safety, Cosmeto- & Nutra-vigilance, Safety of Radio-labeled therapies and EU QPPV services.
My mission is to improve global patient safety through medically sound, technologically advanced pharmacovigilance solutions.
My Journey of Resilience
In 2021, I experienced a stroke causing right hemiparesis and slurred speech. After dedicated rehabilitation, I’ve almost recovered with my motor fumctions, performing my activities of daily living seamlessly & independently; and continuing professional contributions. My story is one of strength and commitment — to science, safety, and service.
Watch the Transition
With the support of a global network of peers, I founded **M/s. PHOENIX NEUMED (a RR Group)**, a non-profit initiative dedicated to providing free, expert-level consulting and training.
Our mission is to equip aspiring healthcare professionals and emerging pharma/CRO organizations with the strategic tools to succeed. We offer pro bono guidance across **the full spectrum of Pharmacovigilance—from xEVMPD setup to PSMF authoring and end-to-end process mastery as well as specialized support in clinical development, data management, and regulatory affairs.**
This work is a way of giving back to the industry I am passionate about. In accordance with professional ethics, my continuation of these services is subject to review based on future employment in pharmacovigilace or patient safety in pharmaceuticals or with health regulators to avoid any conflict of interest.